|
Mutation Information
|
Mutation Site
|
Q148R |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
NNRTIs |
|
Country
|
Italy |
Literature Information
|
PubMed PMID
|
31926287
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2020 |
|
Journal
|
International journal of antimicrobial agents |
|
Title
|
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients. |
|
Author
|
Galizzi N,Poli A,Galli L,Muccini C,Mastrangelo A,Dell'Acqua R,Maillard M,Bossolasco S,Cinque P,Lazzarin A,Castagna A,Gianotti N |
|
Evidence
|
One VF to DTG+RPV occurred because of historical resistance to RPV, accompanied by newly selected G140A and Q148R mutations.
|
|
|
HIV Mutation Detail Information